Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear vs Intratympanic Dexamethasone in Cochlear Implantation
NCT04397354Completed
- Sponsor
- Pamukkale University
- Start
- Mar 2020
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexamethasone in sensorineural hearing loss (SNHL) (3 arms), sponsored by Pamukkale University. Primary endpoints: Electrode Impedance at 6 months and Electrode Thresholds at 6 months. Started Mar 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT04397354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397354.